Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	ASD2	SHROOM4 SHROOM3	1.11e-04	4	81	2	PF08687
Domain	ASD2	SHROOM4 SHROOM3	1.11e-04	4	81	2	PS51307
Domain	Shroom_fam	SHROOM4 SHROOM3	1.11e-04	4	81	2	IPR027685
Domain	ASD2_dom	SHROOM4 SHROOM3	1.11e-04	4	81	2	IPR014799
Domain	CBS	CLCN2 CBS	2.14e-03	16	81	2	SM00116
Domain	CBS_dom	CLCN2 CBS	3.36e-03	20	81	2	IPR000644
Domain	CBS	CLCN2 CBS	3.36e-03	20	81	2	PF00571
Domain	CBS	CLCN2 CBS	3.36e-03	20	81	2	PS51371
Domain	DEP	PIKFYVE PREX2	4.06e-03	22	81	2	PF00610
Domain	DEP	PIKFYVE PREX2	4.06e-03	22	81	2	PS50186
Domain	DEP	PIKFYVE PREX2	4.06e-03	22	81	2	SM00049
Domain	DEP_dom	PIKFYVE PREX2	4.43e-03	23	81	2	IPR000591
Domain	AT_hook	DOT1L AHDC1	6.08e-03	27	81	2	SM00384
Domain	AT_hook_DNA-bd_motif	DOT1L AHDC1	6.08e-03	27	81	2	IPR017956
Domain	PH	PLCH2 IQSEC2 OSBPL8 PREX2 OPHN1	7.20e-03	278	81	5	SM00233
Domain	WD_REPEATS_1	FZR1 EML2 DCAF5 RIC1 WDR24	7.20e-03	278	81	5	PS00678
Domain	WD_REPEATS_2	FZR1 EML2 DCAF5 RIC1 WDR24	7.31e-03	279	81	5	PS50082
Domain	WD_REPEATS_REGION	FZR1 EML2 DCAF5 RIC1 WDR24	7.31e-03	279	81	5	PS50294
Domain	PH_DOMAIN	PLCH2 IQSEC2 OSBPL8 PREX2 OPHN1	7.31e-03	279	81	5	PS50003
Domain	PH_domain	PLCH2 IQSEC2 OSBPL8 PREX2 OPHN1	7.41e-03	280	81	5	IPR001849
Pathway	KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY	PTPN11 ABL2 SRC	3.06e-05	15	59	3	M47816
Pathway	REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY	PTPN11 AGO1 SRC	4.54e-05	17	59	3	M27788
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PIKFYVE ESRP2 HIVEP3 NCOR2 FZR1 SHROOM3 TNRC18 KMT2D NFATC1 PIK3C2B PROM2 MCM3AP EML2 EXTL3 ATG2A DOT1L WASHC2A AHDC1 WNK2 RIC1 WDR24 HR	1.70e-14	1105	85	22	35748872
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PRUNE2 NCOR2 SHROOM3 TNRC18 DISC1 PLCH2 NDFIP2 ATG2A WNK2 RIC1	1.03e-07	430	85	10	35044719
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SHROOM3 ABL2 PIK3C2B IQSEC2 SYNE2 BRSK2 OSBPL8 FAM83G CBARP NCKAP5L PCDH7 CNOT4 LUZP1	1.71e-07	861	85	13	36931259
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	PIKFYVE XIRP1 AGO1 UBAP2L NACAD WNK2 NOTCH4	1.75e-06	233	85	7	37704626
Pubmed	Interaction network of human early embryonic transcription factors.	NCOR2 TNRC18 KMT2D MCM3AP ZFHX3 UHRF2 AHDC1 PRDM2	2.43e-06	351	85	8	38297188
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOR2 TRAF3 SHROOM3 AGO1 UBAP2L IQSEC2 SYNE2 SRC DCHS1 ATP2B4 WNK2 LUZP1	3.90e-06	963	85	12	28671696
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	PIKFYVE CPNE8 SYNE2 OSBPL8 ATG2A WASHC2A PCDH7 RIC1 WDR24	4.07e-06	504	85	9	34432599
Pubmed	Plasma membrane Ca2+-ATPase isoform 4b is phosphorylated on tyrosine 1176 in activated human platelets.	SRC ATP2B4	5.90e-06	2	85	2	12540962
Pubmed	Retinoblastoma protein-interacting zinc finger 1 (RIZ1) participates in RANKL-induced osteoclast formation via regulation of NFATc1 expression.	NFATC1 PRDM2	5.90e-06	2	85	2	20417662
Pubmed	Control of bone resorption in mice by Schnurri-3.	HIVEP3 NFATC1	5.90e-06	2	85	2	22573816
Pubmed	MCM3AP and POMP Mutations Cause a DNA-Repair and DNA-Damage-Signaling Defect in an Immunodeficient Child.	POMP MCM3AP	5.90e-06	2	85	2	26615982
Pubmed	The Ca2+ export pump PMCA clears near-membrane Ca2+ to facilitate store-operated Ca2+ entry and NFAT activation.	NFATC1 ATP2B4	5.90e-06	2	85	2	31594854
Pubmed	Regulation of platelet plasma membrane Ca2+-ATPase by cAMP-dependent and tyrosine phosphorylation.	SRC ATP2B4	5.90e-06	2	85	2	9182531
Pubmed	Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.	PTPN11 SRC	5.90e-06	2	85	2	14687660
Pubmed	APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation via the ubiquitin-proteasome pathway.	FZR1 BRSK2	5.90e-06	2	85	2	23029325
Pubmed	Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.	PTPN11 SRC	5.90e-06	2	85	2	23271399
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CPNE8 SHROOM3 AGO1 ABL2 FAM83G ATG2A NCKAP5L WASHC2A CNOT4 CBX8 LUZP1	7.41e-06	853	85	11	28718761
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	PIKFYVE NCOR2 NFATC1 PIK3C2B MCM3AP DOT1L NCKAP5L WASHC2A LUZP1	1.40e-05	588	85	9	38580884
Pubmed	The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.	NFATC1 ATP2B4	1.77e-05	3	85	2	32860837
Pubmed	Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways.	NFATC1 SRC	1.77e-05	3	85	2	25216923
Pubmed	Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages.	ABL2 SRC	1.77e-05	3	85	2	23100514
Pubmed	Recovery of anoikis in Src-transformed cells and human breast carcinoma cells by restoration of the SIRP α1/SHP-2 signaling system.	PTPN11 SRC	1.77e-05	3	85	2	21169408
Pubmed	Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.	PTPN11 SRC	1.77e-05	3	85	2	10681522
Pubmed	CBX8, a component of the Polycomb PRC1 complex, modulates DOT1L-mediated gene expression through AF9/MLLT3.	DOT1L CBX8	1.77e-05	3	85	2	23891621
Pubmed	PIKfyve-dependent regulation of the Cl- channel ClC-2.	PIKFYVE CLCN2	1.77e-05	3	85	2	19232516
Pubmed	Cell surface glycoprotein PZR is a major mediator of concanavalin A-induced cell signaling.	PTPN11 SRC	1.77e-05	3	85	2	11751924
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	NCOR2 TNRC18 KMT2D	2.41e-05	23	85	3	9225980
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PIKFYVE SHROOM4 HIVEP3 PRUNE2 TNRC18 BRSK2 OSBPL8 RIC1	2.85e-05	493	85	8	15368895
Pubmed	The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2.	PTPN11 SRC	3.53e-05	4	85	2	10206955
Pubmed	A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.	PTPN11 SRC	3.53e-05	4	85	2	22759635
Pubmed	An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.	ABL2 SRC	3.53e-05	4	85	2	21257711
Pubmed	Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.	NCOR2 SRC	3.53e-05	4	85	2	15062576
Pubmed	PECAM1 regulates flow-mediated Gab1 tyrosine phosphorylation and signaling.	PTPN11 SRC	3.53e-05	4	85	2	26706435
Pubmed	SHP-2 is a novel target of Abl kinases during cell proliferation.	PTPN11 ABL2	3.53e-05	4	85	2	18827006
Pubmed	A new standard nomenclature for proteins related to Apx and Shroom.	SHROOM4 SHROOM3	3.53e-05	4	85	2	16615870
Pubmed	Human transcription factor protein interaction networks.	NCOR2 TRAF3 KMT2D AGO1 UBAP2L SYNE2 ZFHX3 GPATCH8 DOT1L WASHC2A PCDH7 DCAF5 PRDM2	4.24e-05	1429	85	13	35140242
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	USP36 NCOR2 PTPN11 KMT2D SYNE2 CBARP NCKAP5L PCDH7 ATP2B4 CBX8 LUZP1	4.96e-05	1049	85	11	27880917
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	NCOR2 TRAF3 SHROOM3 PTPN11 AGO1 ZFHX3 ALAD AHDC1	5.14e-05	536	85	8	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	NCOR2 TRAF3 SHROOM3 PTPN11 AGO1 ZFHX3 ALAD AHDC1	5.28e-05	538	85	8	10512203
Pubmed	Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.	PTPN11 ABL2 SRC	5.45e-05	30	85	3	12522270
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOR2 TNRC18 KMT2D SYNE2 DOT1L NCKAP5L PRDM2	5.59e-05	398	85	7	35016035
Pubmed	A histone methyltransferase is required for maximal response to female sex hormones.	SRC PRDM2	5.87e-05	5	85	2	15282304
Pubmed	The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells.	PTPN11 SRC	5.87e-05	5	85	2	16825188
Pubmed	DUBA: a deubiquitinase that regulates type I interferon production.	TRAF3 OTUD1	5.87e-05	5	85	2	17991829
Pubmed	Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics.	NCOR2 SRC	5.87e-05	5	85	2	12072427
Pubmed	Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding.	DOT1L CBX8	5.87e-05	5	85	2	23260655
Pubmed	Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.	ABL2 SRC	5.87e-05	5	85	2	11494128
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIVEP3 PRUNE2 NCOR2 SHROOM3 TNRC18 NFATC1 PROM2 UBAP2L SRC ZFHX3 AHDC1 WNK2 RIC1	6.44e-05	1489	85	13	28611215
Pubmed	SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome.	PTPN11 ABL2 SRC	6.64e-05	32	85	3	22974441
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ABL2 PIK3C2B SRC OSBPL8 CBARP PCDH7 ATP2B4	7.94e-05	421	85	7	36976175
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ESRP2 NCOR2 SHROOM3 MCM3AP ATP2B4	8.24e-05	180	85	5	35198878
Pubmed	Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.	FZR1 CNOT4	8.80e-05	6	85	2	16365295
Pubmed	Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin.	PTPN11 SRC	8.80e-05	6	85	2	15173175
Pubmed	Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors.	PTPN11 SRC	8.80e-05	6	85	2	12923167
Pubmed	The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling.	TRAF3 SRC	8.80e-05	6	85	2	19419966
Pubmed	SPAP2, an Ig family receptor containing both ITIMs and ITAMs.	PTPN11 SRC	8.80e-05	6	85	2	12051764
Pubmed	Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.	PTPN11 SRC	8.80e-05	6	85	2	8959326
Pubmed	Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation.	PTPN11 SRC	8.80e-05	6	85	2	18378677
Pubmed	CoA Synthase is phosphorylated on tyrosines in mammalian cells, interacts with and is dephosphorylated by Shp2PTP.	PTPN11 SRC	8.80e-05	6	85	2	19763791
Pubmed	Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2.	PTPN11 SRC	8.80e-05	6	85	2	16684964
Pubmed	RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death.	PTPN11 SRC	1.23e-04	7	85	2	11964397
Pubmed	Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1.	NFATC1 SRC	1.23e-04	7	85	2	20037154
Pubmed	The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.	PTPN11 SRC	1.23e-04	7	85	2	12444928
Pubmed	Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily.	SRC PAX1	1.23e-04	7	85	2	8145850
Pubmed	Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans.	NFATC1 SRC	1.23e-04	7	85	2	21982707
Pubmed	A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.	ABL2 SRC	1.23e-04	7	85	2	1383690
Pubmed	Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1.	PTPN11 SRC	1.23e-04	7	85	2	10391903
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	MCM3AP IQSEC2 EXTL3 GPATCH8	1.32e-04	105	85	4	9628581
Pubmed	Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.	PTPN11 SRC	1.64e-04	8	85	2	10801826
Pubmed	Gab3, a new DOS/Gab family member, facilitates macrophage differentiation.	PTPN11 SRC	1.64e-04	8	85	2	11739737
Pubmed	Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.	SRC NDFIP2	1.64e-04	8	85	2	20534535
Pubmed	Black carbon exposures, blood pressure, and interactions with single nucleotide polymorphisms in MicroRNA processing genes.	AGO1 XPO5	1.64e-04	8	85	2	20211803
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	NCOR2 AGO1 UBAP2L KANK4 WASHC2A PREX2 OPHN1	1.67e-04	475	85	7	31040226
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	NCOR2 TNRC18 PTPN11 KANK4 FAM83G IRGQ GPATCH8 NCKAP5L WASHC2A AHDC1 OPLAH	1.81e-04	1215	85	11	15146197
Pubmed	Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase.	ABL2 SRC	2.10e-04	9	85	2	25624478
Pubmed	Calcineurin-independent regulation of plasma membrane Ca2+ ATPase-4 in the vascular smooth muscle cell cycle.	NFATC1 ATP2B4	2.10e-04	9	85	2	12660151
Pubmed	The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor.	NCOR2 HR	2.10e-04	9	85	2	11641275
Pubmed	Host-mediated ubiquitination of a mycobacterial protein suppresses immunity.	FZR1 PTPN11	2.10e-04	9	85	2	31942069
Pubmed	Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome.	PTPN11 NFATC1	2.10e-04	9	85	2	19017799
Pubmed	A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation.	PTPN11 SRC	2.10e-04	9	85	2	15574420
Pubmed	Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis.	FZR1 SRC	2.10e-04	9	85	2	31420536
Pubmed	Shroom2, a myosin-VIIa- and actin-binding protein, directly interacts with ZO-1 at tight junctions.	SHROOM4 SHROOM3	2.10e-04	9	85	2	17666436
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PIK3C2B UBAP2L OTUD1 MCM3AP IQSEC2 CRYBG1 ATG2A NCKAP5L WASHC2A CNOT4	2.22e-04	1038	85	10	26673895
Pubmed	CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.	DOT1L CBX8	2.62e-04	10	85	2	22094252
Pubmed	Gab1 is an integrator of cell death versus cell survival signals in oxidative stress.	PTPN11 SRC	2.62e-04	10	85	2	12808090
Pubmed	Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study.	AGO1 XPO5	2.62e-04	10	85	2	20721975
Pubmed	Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons.	PTPN11 SRC	2.62e-04	10	85	2	15062102
Pubmed	Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.	NCOR2 SRC	2.62e-04	10	85	2	15001550
Pubmed	delta-Protocadherins: a gene family expressed differentially in the mouse brain.	PCDH7 CDH8	3.20e-04	11	85	2	15905963
Pubmed	Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase.	PTPN11 OLIG1	3.20e-04	11	85	2	20648636
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP36 SHROOM3 PLCH2 ATG2A NACAD KIAA1614 WNK2	3.21e-04	529	85	7	14621295
Pubmed	New nomenclature for chromatin-modifying enzymes.	KMT2D DOT1L PRDM2	3.75e-04	57	85	3	18022353
Pubmed	Murine chromosomal location of four hepatocyte-enriched transcription factors: HNF-3 alpha, HNF-3 beta, HNF-3 gamma, and HNF-4.	SRC PAX1	3.83e-04	12	85	2	1612587
Pubmed	Regulation of neuronal migration by Dchs1-Fat4 planar cell polarity.	DCHS1 CDH8	3.83e-04	12	85	2	24998526
Pubmed	Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.	DOT1L AHDC1	3.83e-04	12	85	2	28700933
Pubmed	Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2.	NCOR2 SRC	3.83e-04	12	85	2	11158331
Pubmed	Meta-analysis identifies six new susceptibility loci for atrial fibrillation.	SYNE2 ZFHX3	3.83e-04	12	85	2	22544366
Pubmed	Amelogenesis imperfecta in a new animal model--a mutation in chromosome 5 (human 4q21).	SHROOM3 TNRC18	3.83e-04	12	85	2	15271968
Pubmed	Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.	HIVEP3 NFATC1	3.83e-04	12	85	2	15790681
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	NCOR2 FZR1 AGO1 ABL2 SRC BRSK2 OSBPL8 GPATCH8 LUZP1	3.85e-04	910	85	9	36736316
Interaction	TOP3B interactions	PIKFYVE ESRP2 HIVEP3 NCOR2 FZR1 SHROOM3 TNRC18 KMT2D NFATC1 XPO5 PIK3C2B PROM2 UBAP2L MCM3AP EML2 EXTL3 ATG2A DOT1L WASHC2A AHDC1 WNK2 RIC1 WDR24 HR	2.95e-09	1470	83	24	int:TOP3B
Interaction	YWHAE interactions	NCOR2 FZR1 SHROOM3 ABL2 PIK3C2B DISC1 OTUD1 IQSEC2 SRC BRSK2 OSBPL8 FAM83G CBARP DOT1L NCKAP5L PCDH7 ATP2B4 CNOT4 WNK2 LUZP1	1.26e-07	1256	83	20	int:YWHAE
Interaction	TLE3 interactions	NCOR2 TNRC18 KMT2D MCM3AP ZFHX3 GPATCH8 DOT1L AHDC1 CNOT4	2.42e-05	376	83	9	int:TLE3
Interaction	YWHAG interactions	FZR1 TRAF3 SHROOM3 ABL2 PIK3C2B DISC1 IQSEC2 SYNE2 SRC OSBPL8 FAM83G CBARP NCKAP5L PCDH7 CNOT4 LUZP1	4.27e-05	1248	83	16	int:YWHAG
Interaction	NUP43 interactions	USP36 NCOR2 KMT2D MCM3AP SYNE2 ZFHX3 XPC GPATCH8 AHDC1 CBX8 PRDM2	4.98e-05	625	83	11	int:NUP43
Interaction	DEFB114 interactions	SRC CRYBG1	5.01e-05	3	83	2	int:DEFB114
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 TNRC18 KMT2D	7.59e-05	25	60	3	775
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2D DOT1L PRDM2	1.93e-04	34	60	3	487
GeneFamily	X-linked mental retardation\|Angiotensin receptors	ZNF41 IQSEC2 OPHN1	7.23e-04	53	60	3	103
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#5_top-relative-expression-ranked_1000	ESRP2 CPNE8 PROM2 PLCH2 SRC CRYBG1	4.95e-05	167	83	6	gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_500	ESRP2 CPNE8 PROM2 PLCH2 CRYBG1	5.00e-05	102	83	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k3
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CPNE8 ADCY4 PIK3C2B SYNE2 PREX2 NOTCH4	1.23e-06	179	85	6	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SYNE2 ZFHX3 DOT1L NCKAP5L ATP2B4	1.49e-06	185	85	6	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SYNE2 ZFHX3 DOT1L NCKAP5L ATP2B4	1.49e-06	185	85	6	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR2 PLCH2 FAM167A CBARP NCKAP5L HR	1.54e-06	186	85	6	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHROOM4 ADCY4 PIK3C2B SYNE2 ATP2B4 PREX2	1.54e-06	186	85	6	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ADCY4 KANK4 PREX2 NOTCH4 HR	1.63e-06	188	85	6	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR2 PLCH2 FAM167A CBARP NCKAP5L HR	1.69e-06	189	85	6	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR2 CPNE8 PLCH2 FAM83G NCKAP5L HR	1.79e-06	191	85	6	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	SHROOM4 ADCY4 PIK3C2B SYNE2 PREX2 NOTCH4	1.85e-06	192	85	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 CPNE8 ADCY4 KANK4 PREX2 NOTCH4	1.85e-06	192	85	6	144503af50274eaed5cf6effa892c640eab28663
ToppCell	droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 CPNE8 ADCY4 KANK4 PREX2 NOTCH4	1.85e-06	192	85	6	c96736bb3a6bb052678b1b078f7823063ca69e6d
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CPNE8 ADCY4 PIK3C2B ATP2B4 PREX2 NOTCH4	1.90e-06	193	85	6	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	SHROOM4 CPNE8 ADCY4 SYNE2 PREX2 NOTCH4	2.02e-06	195	85	6	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	SHROOM4 CPNE8 ADCY4 SYNE2 PREX2 NOTCH4	2.14e-06	197	85	6	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	ASK452-Endothelial-Endothelium\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	SHROOM4 PIK3C2B SYNE2 PREX2 LUZP1 NOTCH4	2.21e-06	198	85	6	e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	SHROOM4 ADCY4 PIK3C2B SYNE2 PREX2 NOTCH4	2.21e-06	198	85	6	531b0f88c95f813e3914c96749f591e80ca321d0
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	SHROOM4 ADCY4 PIK3C2B SYNE2 PREX2 NOTCH4	2.27e-06	199	85	6	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HIVEP3 XIRP1 ABL2 NFATC1 DOT1L LUZP1	2.27e-06	199	85	6	b0a906586e58009f5ed9272fc29ba28e49c85ee6
ToppCell	ASK452-Endothelial\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	SHROOM4 PIK3C2B SYNE2 PREX2 LUZP1 NOTCH4	2.27e-06	199	85	6	0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SHROOM4 CPNE8 SYNE2 KIAA1755 PREX2 NOTCH4	2.34e-06	200	85	6	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM4 ADCY4 ABL2 PIK3C2B PREX2 NOTCH4	2.34e-06	200	85	6	5ec31c1be6bcc4124e1489d136570f3de33cc2e9
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SHROOM4 CPNE8 SYNE2 KIAA1755 PREX2 NOTCH4	2.34e-06	200	85	6	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SHROOM4 CPNE8 SYNE2 KIAA1755 PREX2 NOTCH4	2.34e-06	200	85	6	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	distal-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SHROOM4 WASHC2A ATP2B4 LUZP1 NOTCH4 OPHN1	2.34e-06	200	85	6	7a99f28670ffb8ece7873d8a9bcd2a3936d0255d
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SHROOM4 CPNE8 SYNE2 KIAA1755 PREX2 NOTCH4	2.34e-06	200	85	6	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SHROOM4 CPNE8 SYNE2 KIAA1755 PREX2 NOTCH4	2.34e-06	200	85	6	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SHROOM4 CPNE8 SYNE2 KIAA1755 PREX2 NOTCH4	2.34e-06	200	85	6	7136936d05ab344a560cf159684c881063b5430d
ToppCell	COVID-19_Mild-PLT_5\|World / Disease Group and Platelet Clusters	SHROOM3 SYNE2 KIAA1755 WASHC2A ATP2B4	1.09e-05	152	85	5	90ba4e8a735ec8921038fa072129535f0e3fd9ae
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ESRP2 XPO5 SYNE2 ATG2A ATP2B4	1.39e-05	160	85	5	79e833c904c762434993b5ec9d5e3540e695fad3
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	PRUNE2 HMCN2 CBARP PCDH7 CBX8	1.71e-05	167	85	5	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	HMCN2 KCNC4 PROM2 CBX8 NOTCH4	1.76e-05	168	85	5	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	Endothelial-A-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ADCY4 PIK3C2B DCHS1 PREX2 NOTCH4	1.97e-05	172	85	5	a3201773a25832e92dd113fad165f1ecd37f5e91
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel\|Adult / Lineage, Cell type, age group and donor	ADCY4 KCNC4 DCHS1 PREX2 NOTCH4	1.97e-05	172	85	5	ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PROM2 BRSK2 EXTL3 CBS RIC1	2.03e-05	173	85	5	c62e3ffed55bbb00dcaef6da0aab8446f3f55085
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PROM2 BRSK2 EXTL3 CBS RIC1	2.03e-05	173	85	5	f612d4ea9ab8dcde475f4118bca3e49be786e7fa
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CPNE8 ADCY4 PIK3C2B CRYBG1 NOTCH4	2.33e-05	178	85	5	c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	SHROOM4 ADCY4 SYNE2 PREX2 NOTCH4	2.52e-05	181	85	5	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHROOM4 PIK3C2B SYNE2 PREX2 LUZP1	2.52e-05	181	85	5	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	SHROOM4 ADCY4 DCHS1 PREX2 NOTCH4	2.59e-05	182	85	5	d7cce5dd7046f06bf40f00c9dbfa610722b03333
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SRC FAM167A FAM83G CBS OPHN1	2.66e-05	183	85	5	6e5b39c0170d62eb7fdd411dcfff51ed176573d0
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 TRAF3 PTPN11 PIK3C2B LUZP1	2.73e-05	184	85	5	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ADCY4 HMCN2 PIK3C2B PREX2 NOTCH4	2.73e-05	184	85	5	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HMCN2 BRSK2 NACAD ATP2B4	2.73e-05	184	85	5	590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHROOM4 DISC1 OLIG1 PREX2 OPHN1	2.80e-05	185	85	5	efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	2.80e-05	185	85	5	808d5e880069aff8866cd2c733b9fe568a37701f
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHROOM4 DISC1 OLIG1 PREX2 OPHN1	2.80e-05	185	85	5	fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	CPNE8 PIK3C2B SYNE2 PREX2 NOTCH4	2.95e-05	187	85	5	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ADCY4 KANK4 PREX2 NOTCH4	2.95e-05	187	85	5	e93cad16a087d1443cbf4e1690dc1b35d7a84c41
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	SHROOM4 ADCY4 DCHS1 PREX2 NOTCH4	2.95e-05	187	85	5	be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4
ToppCell	Endothelial-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SHROOM4 ADCY4 DCHS1 PREX2 NOTCH4	3.02e-05	188	85	5	0824d567356d360fd8e78e840c30529c139f98a1
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM4 ATP2B4 PREX2 NOTCH4 OPHN1	3.10e-05	189	85	5	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY4 HMCN2 PIK3C2B PREX2 NOTCH4	3.10e-05	189	85	5	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SHROOM4 KIAA1755 ZFHX3 OLIG1 PREX2	3.10e-05	189	85	5	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.10e-05	189	85	5	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	COVID-19-lung-Artery_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CPNE8 ADCY4 PIK3C2B PREX2 NOTCH4	3.18e-05	190	85	5	07b675befcd1d0a9c90cb17b5d22323468325d51
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPNE8 ADCY4 PIK3C2B PREX2 NOTCH4	3.18e-05	190	85	5	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ADCY4 KANK4 PREX2 NOTCH4	3.18e-05	190	85	5	cb8798839c27f307955fcc94a1ee40bca95b8e99
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ADCY4 KANK4 PREX2 NOTCH4	3.18e-05	190	85	5	5bf3d0beee69879c95265d07fba023626a7cc808
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ADCY4 SYNE2 ZFHX3 PREX2 NOTCH4	3.18e-05	190	85	5	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.18e-05	190	85	5	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SHROOM4 ADCY4 DCHS1 PREX2 NOTCH4	3.26e-05	191	85	5	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SHROOM4 ABL2 SYNE2 PREX2 NOTCH4	3.26e-05	191	85	5	adb2e3efcad02889d8229325080da5e7830fd3ae
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.26e-05	191	85	5	04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.26e-05	191	85	5	db8dd6bbba803585bdd6a55d5c403d383f2e9acf
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR2 CPNE8 PLCH2 FAM83G NCKAP5L	3.26e-05	191	85	5	2f733d510a4862565a817f59829d8387d7ea26d9
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPNE8 ADCY4 PIK3C2B PREX2 NOTCH4	3.26e-05	191	85	5	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	SHROOM4 PIK3C2B SYNE2 PREX2 NOTCH4	3.26e-05	191	85	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ADCY4 NCKAP5L PREX2 NOTCH4	3.26e-05	191	85	5	b9ae5af426e7a1f2652a47700bb168371bd2dec6
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.34e-05	192	85	5	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP3 CPNE8 NFATC1 PREX2 NOTCH4	3.34e-05	192	85	5	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPNE8 ADCY4 HMCN2 PIK3C2B NOTCH4	3.34e-05	192	85	5	3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	POMP SYNE2 TSEN54 ATG2A ATP2B4	3.34e-05	192	85	5	d9e27b8c2fd64e318a399feb5a51283616e1a30c
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CPNE8 ADCY4 KCNC4 CRYBG1 NOTCH4	3.42e-05	193	85	5	d338a7c0585b69947c37f44aa0381619493e31ea
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.42e-05	193	85	5	1e6e2d786511cc40241197368f5df20c20b882f3
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 PIK3C2B DISC1 PREX2 NOTCH4	3.42e-05	193	85	5	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	IPF-Endothelial-VE_Arterial\|IPF / Disease state, Lineage and Cell class	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.42e-05	193	85	5	bf83b1fe9d38408f30eee4eb634341c04ef82791
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY4 HMCN2 PIK3C2B PREX2 NOTCH4	3.42e-05	193	85	5	cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell	IPF-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.42e-05	193	85	5	70a9aadda83a97e06e9bc2d1327ce60dd3c58767
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	SHROOM4 ADCY4 SYNE2 PREX2 NOTCH4	3.42e-05	193	85	5	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CPNE8 ADCY4 CRYBG1 CDH8 NOTCH4	3.51e-05	194	85	5	3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 KCNC4 CRYBG1 DOT1L PCDH7	3.51e-05	194	85	5	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	SHROOM4 ADCY4 SYNE2 PREX2 NOTCH4	3.51e-05	194	85	5	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 KCNC4 CRYBG1 DOT1L PCDH7	3.51e-05	194	85	5	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	EC-Arteriolar_ECs\|World / Lineage and Cell class	PRUNE2 ADCY4 PREX2 LUZP1 NOTCH4	3.51e-05	194	85	5	38f0c52de252101d4bc8633af80002061635e487
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.51e-05	194	85	5	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM4 CPNE8 ADCY4 PREX2 NOTCH4	3.51e-05	194	85	5	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY4 HMCN2 PIK3C2B PREX2 NOTCH4	3.60e-05	195	85	5	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	SHROOM4 ADCY4 SYNE2 PREX2 NOTCH4	3.60e-05	195	85	5	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	Endothelial-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	SHROOM4 PIK3C2B DCHS1 LUZP1 NOTCH4	3.60e-05	195	85	5	c3a0aa34b672c99cb3a2a4e9218412dbd19da3ca
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	USP36 HIVEP3 SYNE2 UHRF2 OPHN1	3.60e-05	195	85	5	e06ff785c5542c86c335d956799e03f7ae8345a4
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.60e-05	195	85	5	023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	SHROOM4 ADCY4 SYNE2 PREX2 NOTCH4	3.60e-05	195	85	5	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SHROOM4 ADCY4 PIK3C2B PREX2 NOTCH4	3.60e-05	195	85	5	a432d69b0172211ee4d53675936a1dc9ce1ae1f0
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	DISC1 OSBPL8 CRYBG1 ATP2B4 LUZP1	3.60e-05	195	85	5	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	PROM2 PLCH2 SYNE2 PCDH7 HR	3.69e-05	196	85	5	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADCY4 PIK3C2B DCHS1 PREX2 NOTCH4	3.69e-05	196	85	5	915e4a7422058be246b54760df31e8a607310625
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HIVEP3 ADCY4 PIK3C2B PREX2 NOTCH4	3.69e-05	196	85	5	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	DISC1 OSBPL8 CRYBG1 ATP2B4 LUZP1	3.69e-05	196	85	5	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HIVEP3 SYNE2 TSEN54 ATG2A ATP2B4	3.78e-05	197	85	5	8e41e6cda38eace961cb1a56f4df24468c66b956
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SHROOM4 ADCY4 SYNE2 PREX2 NOTCH4	3.78e-05	197	85	5	f969685dee212f33a6f09e54c0cd1fd24ffef546
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	DISC1 IQSEC2 SRC AHDC1 CBX8 LUZP1 HR	8.42e-06	197	84	7	6011_DN
Drug	triacetylene	CBS CBX8	1.35e-05	2	84	2	CID000137843
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	FZR1 NFATC1 IQSEC2 EML2 ZFHX3 XPC	7.83e-05	192	84	6	4462_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	HIVEP3 FZR1 IQSEC2 SRC EML2 PRDM2	8.29e-05	194	84	6	6955_UP
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A	FZR1 EXTL3 ATP2B4 CNOT4 CBX8 PRDM2	8.53e-05	195	84	6	6845_DN
Drug	Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	IQSEC2 SRC ZFHX3 CBS ATP2B4 CNOT4	8.53e-05	195	84	6	4309_UP
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	HIVEP3 FZR1 IQSEC2 EML2 CNOT4 HR	8.53e-05	195	84	6	4368_DN
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	FZR1 CLCN2 SRC IRGQ LUZP1 PRDM2	8.77e-05	196	84	6	2645_DN
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	DISC1 IQSEC2 SRC EML2 EXTL3 PREX2	8.77e-05	196	84	6	6898_DN
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A	IQSEC2 SRC PCDH7 CNOT4 CBX8 HR	8.77e-05	196	84	6	3217_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PIK3C2B DISC1 SRC CNOT4 CBX8 LUZP1	8.77e-05	196	84	6	2889_DN
Drug	Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A	NCOR2 FZR1 ABL2 CDH8 CNOT4 PRDM2	9.02e-05	197	84	6	3065_DN
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A	FZR1 IQSEC2 BRSK2 EXTL3 CNOT4 PRDM2	9.02e-05	197	84	6	2122_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	NCOR2 NFATC1 IQSEC2 SRC ATG2A HR	9.02e-05	197	84	6	3639_UP
Drug	Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	PRUNE2 NCOR2 FZR1 DISC1 CBARP HR	9.02e-05	197	84	6	7358_UP
Drug	Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	NCOR2 IQSEC2 ZFHX3 ATP2B4 LUZP1 HR	9.02e-05	197	84	6	2645_UP
Drug	(R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A	HIVEP3 PRUNE2 NCOR2 MCM3AP PCDH7 HR	9.02e-05	197	84	6	6096_UP
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	FZR1 CLCN2 EML2 PCDH7 ATP2B4 LUZP1	9.28e-05	198	84	6	4703_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	HIVEP3 DISC1 IQSEC2 ZFHX3 CNOT4 CBX8	9.28e-05	198	84	6	4005_DN
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A	HIVEP3 FZR1 IQSEC2 SRC AHDC1 LUZP1	9.28e-05	198	84	6	4805_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	DISC1 IQSEC2 SRC ATP2B4 CNOT4 LUZP1	9.28e-05	198	84	6	6001_DN
Drug	BAS 012416453; Up 200; 38uM; PC3; HT_HG-U133A	ABL2 NFATC1 DISC1 MCM3AP CBS HR	9.54e-05	199	84	6	6876_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	USP36 FZR1 CLCN2 MCM3AP SRC ZFHX3	9.54e-05	199	84	6	7439_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HIVEP3 FZR1 DISC1 SRC CBX8 LUZP1	9.54e-05	199	84	6	4119_DN
Drug	FK-506; Down 200; 1uM; MCF7; HG-U133A	FZR1 ABL2 ALAD PAX1 PCDH7 LUZP1	9.81e-05	200	84	6	378_DN
Disease	Mental Retardation, X-Linked	ZNF41 IQSEC2 OPHN1	6.92e-05	29	81	3	C1136249
Disease	cortical surface area measurement	SHROOM3 CLCN2 BRSK2 KIAA1755 EML2 ZFHX3 EXTL3 OLIG1 PCDH7 KIAA1614 CNOT4 WNK2 LUZP1	7.23e-05	1345	81	13	EFO_0010736
Disease	Neurodevelopmental Disorders	HIVEP3 PTPN11 IQSEC2 BRSK2	1.28e-04	93	81	4	C1535926
Disease	Colorectal Carcinoma	HIVEP3 NFATC1 MCM3AP SRC DCHS1 EML2 UHRF2 PREX2 HR	1.32e-04	702	81	9	C0009402
Disease	Lead Poisoning	XPO5 ALAD	1.55e-04	7	81	2	C0023176
Disease	ductal carcinoma in situ (is_implicated_in)	SRC NOTCH4	1.55e-04	7	81	2	DOID:0060074 (is_implicated_in)
Disease	mouth morphology measurement	NFATC1 POMP PCDH7	3.56e-04	50	81	3	EFO_0007955
Disease	right ventricular stroke volume measurement	PTPN11 KIAA1755	4.83e-04	12	81	2	EFO_0021817
Disease	bitter alcoholic beverage consumption measurement	CPNE8 ZFHX3 OLIG1 CDH8	5.02e-04	133	81	4	EFO_0010092
Disease	colon carcinoma (is_marker_for)	KMT2D SRC	5.69e-04	13	81	2	DOID:1520 (is_marker_for)
Disease	arterial stiffness measurement	CPNE8 DISC1 RIC1	7.36e-04	64	81	3	EFO_0004517
Disease	brain measurement, neuroimaging measurement	BRSK2 KIAA1755 ZFHX3 GPATCH8 WNK2 CBX8 LUZP1	7.96e-04	550	81	7	EFO_0004346, EFO_0004464
Disease	cortical thickness	SHROOM3 XPO5 KIAA1755 EML2 OLIG1 PCDH7 KIAA1614 WNK2 CBX8 LUZP1	9.28e-04	1113	81	10	EFO_0004840
Disease	sphingomyelin 14:0 measurement	SYNE2 ZFHX3	9.85e-04	17	81	2	EFO_0010390
Disease	myeloid white cell count	HIVEP3 PRUNE2 KIAA1755 ZFHX3 DOT1L CBS ATP2B4 KIAA1614 PREX2	1.07e-03	937	81	9	EFO_0007988
Disease	leukemia (implicated_via_orthology)	PTPN11 DOT1L	1.23e-03	19	81	2	DOID:1240 (implicated_via_orthology)
Disease	cardioembolic stroke	NCOR2 SYNE2 KIAA1755 ZFHX3	1.25e-03	170	81	4	EFO_1001976
Disease	citrate measurement	SHROOM3 NFATC1 WNK2	1.36e-03	79	81	3	EFO_0010114
Disease	Agouti-related protein measurement	ESRP2 FZR1	2.50e-03	27	81	2	EFO_0008016
Disease	testosterone measurement	SHROOM4 NCOR2 SHROOM3 NFATC1 IQSEC2 SYNE2 ZFHX3 ATP2B4 CBX8 OPHN1	2.54e-03	1275	81	10	EFO_0004908
Disease	lung small cell carcinoma (is_implicated_in)	KMT2D XPO5	2.69e-03	28	81	2	DOID:5409 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
QHSDPGARAAPALAG	CBARP	586	Q8N350
DKTGGSSPEALHRPY	ABL2	66	P42684
FLGADVTHPPAGDGK	AGO1	591	Q9UL18
GAAKPFAHLSHGDSP	ADCY4	486	Q8NFM4
FSDGASLPHKGPEAA	DOT1L	1331	Q8TEK3
DSPSLGAPELDGKHF	AHDC1	1366	Q5TGY3
GAKAASLDGPHEDPR	DISC1	246	Q9NRI5
FFDIDSGRKAPLHSP	ATP2B4	941	P23634
ATKDGPFGSRDFHHL	ATG2A	461	Q2TAZ0
HLDPGFLASDKTSAG	C18orf25	301	Q96B23
EHKPSREKSPFADGG	RIC1	451	Q4ADV7
PRPLAHHKEGDADSF	OPHN1	711	O60890
DTGHAFLAKPPARSG	NCOR2	1951	Q9Y618
ASDADPGPHGLVRFT	DCHS1	2626	Q96JQ0
ALAAAKHRGPAATPG	OTUD1	201	Q5VV17
KSLDKAGSESPHPGR	NCKAP5L	621	Q9HCH0
GPFRDAAKSSPAFGD	ALAD	206	P13716
AEDGKGSHKLPDPAR	KIAA1755	1136	Q5JYT7
GSHAFLPCKARGSPE	HMCN2	4046	Q8NDA2
GPAHPGREKEAGYSA	IQSEC2	176	Q5JU85
EDAPFQHSPLGKAAG	MCM3AP	531	O60318
AGPGDHSAAGRPAKT	KIAA1614	1086	Q5VZ46
TPAKRSAHGPLGDSA	BRSK2	691	Q8IWQ3
HSGGHLKSDPVAFRP	HR	126	O43593
KSGEATADHPVAPLG	GPATCH8	1211	Q9UKJ3
GPGSPDLARHYKSSS	PCDH7	986	O60245
FLSSGHTRPDGAPAL	NFATC1	101	O95644
EGRAGTSHKDNPAPS	DCAF5	691	Q96JK2
DGSFLARPSKSNPGD	PTPN11	26	Q06124
SGAHPGGSARPDAKE	OLIG1	86	Q8TAK6
FEKGPLSPRFRGEHA	NDUFS8	86	O00217
GGDKPSSRFHDFVDL	PIK3C2B	1246	O00750
ASGPFESHDLLRKGF	POMP	21	Q9Y244
PASPHSQGFERGKED	OSBPL8	66	Q9BZF1
GAEHGEDSLSRKPDP	NDFIP2	76	Q9NV92
FKHPSREGSLPAPAA	PAX1	421	P15863
RKAEPTFGGHDPRTA	PIKFYVE	111	Q9Y2I7
PSKHGDRFIPSRAGA	FZR1	41	Q9UM11
LDDTPSGAGKFPAGH	CBX8	231	Q9HC52
AEIPHRSGKAAGTDP	EXTL3	551	O43909
GLNDHGDFVTPPFRK	IGFLR1	61	Q9H665
PHSAKGSLEKGSPED	CBS	21	P35520
HGSVPSDPLGRADKA	LUZP1	516	Q86V48
PAEGLAGFHSSSPRA	KANK4	206	Q5T7N3
IIEDPARSAGFHPSG	EML2	416	O95834
HIDPRFSGRGPFKDT	CDH8	361	P55286
PGASDADGLKPRNHF	CRYBG1	206	Q9Y4K1
GAKLPPDGRISHEFA	CPNE8	366	Q86YQ8
LASGELAARAHFPGP	IRGQ	536	Q8WZA9
HSPALRDFGKPSDGK	PRDM2	746	Q13029
GEKHRPPGPLFSSSD	POM121L1P	316	Q3SYA9
HRVPASGTRDKDGFP	FAM83G	701	A6ND36
GAGAAAPPDDHLRSL	FAM167A	16	Q96KS9
PASADGHRGPSAAFA	SRC	41	P12931
GHRGPSAAFAPAAAE	SRC	46	P12931
PGARALFDGDPHLST	PRUNE2	2261	Q8WUY3
RSHGPKDFLPDGSAA	TSEN54	36	Q7Z6J9
GGDPHSEAPFAKSDN	SYNE2	1061	Q8WXH0
SDGSHSKGDGIPDRF	IGLV4-3	71	A0A075B6K6
HPATARSPRAGDFGA	OPLAH	596	O14841
PQTRKGSHAPAGEFA	GNRHR2	146	Q96P88
GSHAPAGEFALPRSF	GNRHR2	151	Q96P88
AEDPGRKAAPDLGSH	SHROOM3	701	Q8TF72
DGHPSEKGFLDPNRT	SHROOM4	501	Q9ULL8
HPDGRPTGDAFALFA	ESRP2	396	Q9H6T0
EARHKATPGREAGPF	NOTCH4	1826	Q99466
DSAFPAARGETHKPL	CLCN2	681	P51788
AKGPGSGFLHPAAAT	CNOT4	446	O95628
PGAHPLSFADGKFLR	UHRF2	311	Q96PU4
ARGQPKSAHSPFASE	TNRC18	1711	O15417
RHLGDAFKPDPNSSS	TRAF3	506	Q13114
DLTKFGRGDASSPAP	UBAP2L	861	Q14157
ARDDPSHPEAKGEAG	PROM2	456	Q8N271
GHEGSVDAPAPSKGA	PLCH2	1386	O75038
RDDHGKAEAPSPSSD	HIVEP3	951	Q5T1R4
KGADHSSAPPADGDD	XPO5	981	Q9HAV4
SHSKPPGDEAGDAFD	PREX2	771	Q70Z35
KGRDPDAHPKSTGVF	WASHC2A	826	Q641Q2
PGPKGRSSADHAALN	ZNF41	46	P51814
RHPHDPSFLLSGSKD	WDR24	306	Q96S15
TGHLADSSRGPPAKD	WNK2	2011	Q9Y3S1
GPKSEAAAPHTDAGG	XPC	866	Q01831
PEASARGHFQGPPKD	XIRP1	1566	Q702N8
KTEGASRHKSGDDPP	USP36	66	Q9P275
RPHEEPGAAAGSSSK	ZFHX3	506	Q15911
KGDIFDGTSFSHLPP	ZFHX3	2761	Q15911
GARPSDPRGNDHTDF	KCNC4	406	Q03721
EKASFGATGGPPAHL	KMT2D	3181	O14686
ARAHTGDGAKPDSPQ	NACAD	1056	O15069